The European Medicines Agency has started a review of high-strength oestradiol creams after EU Court of Justice decision.

Data from the UK Biobank for half a million men and women aged 40-69 years.

The move has been met with criticism.

Risks increased steadily with decreasing awareness about financial, other scams.

No major sex-based risk differences, but important differences in risk factor management.

A big leap from age 10 to 16 years is also ominous.

Effect is most pronounced in patients with more advanced liver disease.

Results of a real-world analysis of first-line treatment for hypertension.

No overall decrease in relapse, death risks vs placebo.

The World Medical Association says even advising or preparing for some of the punishments would constitute a gross violation of medical ethics.

Exploring the impacts of the 2012 Health and Social Care Act reforms on clinical activity in the English NHS.

The tool which was piloted last year will be made more widely available.

A non-antibiotic drug–bacteria screen identified novel interactions, suggesting that some human-targeted drugs significantly impact the gut microbiome, potentially causing side effects and antibiotic resistance. This screen is a resource of representative gut bacteria strains and growth media for further in vitro studies.

Real-world data on persistence and adherence with oral bisphosphonates.